Horizon Therapeutics Public Ltd Co

FIL Ltd

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/13/2023

Shares

2,118,702

Value ($000)

245,113

Weight

0.3%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/13/2023	245,113	0.3%	2,118,702	9/30/2023
2023 Q2	8/11/2023	308,958	0.3%	3,003,963	6/30/2023
2023 Q1	5/11/2023	323,828	0.4%	2,967,084	3/31/2023
2022 Q4	2/13/2023	319,542	0.4%	2,807,928	12/31/2022
2022 Q3	11/10/2022	64,857	0.1%	1,047,936	9/30/2022
2022 Q2	8/12/2022	228,679	0.3%	2,867,093	6/30/2022
2022 Q1	5/13/2022	273,734	0.3%	2,601,790	3/31/2022
2021 Q4	2/14/2022	197,356	0.2%	1,831,440	12/31/2021
2021 Q3	11/15/2021	79,997	0.1%	730,299	9/30/2021
2021 Q2	8/13/2021	63,429	0.1%	677,370	6/30/2021
2021 Q1	5/14/2021	58,657	0.1%	637,303	3/31/2021
2020 Q4	3/23/2021	43,309	0.1%	592,056	12/31/2020
2020 Q3	11/13/2020	59,958	0.1%	771,861	9/30/2020
2020 Q2	8/13/2020	38,873	0.1%	699,412	6/30/2020
2020 Q1	5/14/2020	22,221	0.0%	750,213	3/31/2020
2019 Q4	2/7/2020	25,678	0.0%	709,330	12/31/2019